Intended Learners

This educational activity is designed for advanced practice registered nurses, nurse practitioners and other nursing professionals, physicians, podiatrists, pharmacists, physician associates/assistants, and dietitians. 

Learning Objectives

After participating in this activity, learners should be better able to:

• Examine how different pharmacologic agents affect wounds and their healing processes

• Summarize adjunctive therapies that may be used in conjunction with medication therapy for acute and chronic wounds

• Identify methods for managing soft tissue and bone infections, bioburden, and local and systemic infections

• Employ an appropriate therapeutic regimen that maximizes therapeutic effectiveness while minimizing adverse reactions

Activity Overview

This on-demand webcast is available with synchronized slides and video/audio. 

To be eligible for documentation of credit for each session attended, learners must participate in the activity and complete the activity evaluation. Participants who complete the evaluation online within active dates of the training will receive documentation of credit. Your certificate may not load if you are accessing it from a smartphone, or settings of your browser do not allow for a new tab/window to open.  

Once a certificate has been claimed, physicians and pharmacists may elect for credits to be submitted on their behalf to their boards via additional fields that will appear within the Claim Certificate page. Credits must be submitted through this process to be reported to the American Board of Surgery and the National Association of Boards of Pharmacy. 

Release Date: February 29, 2024
Expiration Date: February 28, 2026
Estimated Time to Complete: 39.75 hours 

Hardware/Software Requirements

The activity is best supported via a computer or device with a current version of one of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print content.

 

Accreditation Statement 

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.

Provider Statement

Provided by HMP Education, an HMP Global Company.

Credit Designation Statements

Physicians

HMP Education designates this enduring activity for 39.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists 

This enduring, knowledge-based activity (Universal Activity Number JA0006201-0000-24-033-H01-P) has been approved for 39.75 contact hours (3.975 CEUs).

 Note: The certificate is not the official record of your participation in the activity. The official record of credit will be the information in the CPE Monitor system. Following ACPE Policy, credit must be transmitted to NABP through CPE Monitor within 60 days from the date you complete this CPE activity. 

Nurses

This continuing nursing education enduring activity awards 39.75 contact hours. 

Provider approved by the California Board of Registered Nursing, Provider #18006 for 39.75 contact hours.

This activity will also award 25.00 pharmacotherapeutic contact hours.

Nurse Practitioners

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

Physician Assistants/Associates 

HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This enduring activity is designated for 39.75 AAPA Category 1 credits. Approval is valid until February 28, 2026. PAs should claim only the credit commensurate with the extent of their participation.

Dietitians 

International Recognition  

Visit this link for Countries and Regions have reciprocity with the ACCME.  

Visit this link for additional countries that accept ACCME-accredited continuing medical education (CME). 

Disclosure of Relevant Financial Relationships

HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real relevant financial relationship (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME.

Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:

1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;

2. Any investigational, off-label, or non-FDA approved content or discussion

HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.

Education has been independently peer-reviewed to validate content, mitigate identified financial relationships (conflicts of interest), and ensure:

1. All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.

2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.

3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.

All relevant financial relationships have been mitigated.

Faculty

The faculty has reported the following:

Maria Abreu: Consultant, advisory board – AbbVie, Amgen, Bristol Myers Squibb, Celsius Therapeutics, Eli Lilly, Gilead Sciences, Janssen Pharmaceuticals, Microba Life Sciences, Pfizer, Prometheus Biosciences, UCB Biopharma SRL; research funding – National Institute of Health Research, DOD, Leona M. and Harry B. Helmsley Charitable Trust​

Afsaneh Alavi: Consultant—Abbvie, JAnssen, Novartis, InflaRx, BI , UCB

Oscar Alvarez: Advisory Board—Cell Constructs LLC, Molnlycke; Consultant—BioCompression Inc Scientific ; Grant/Research Support—Molnlycke Health Care Sanuwave, Inc

Andrew Boulton: Consultant—Bayer Pharmaceuticals Inc, German,. Astra Zeneca.

Abigail Chaffin: Consultant—AROA Biosurgery, Urgo Medical North America

Amanda Killeen: Grant/Research Support—3M/KCI, Acera Surgical, American Diabetes Association, AstraZeneca, BioTissue Surgical, Hologenix LLC, Integra LifeSciences, Kent Imaging, Microbion Biosciences, Polarity TE, Smith+Nephew, Stark Enterprises, LLC, VasoActiv, ViOptix, Xyken

Robert Kirsner: Consultant—Pfizer Inc,  Smith & Nephew

Kathryn Kreider: Advisory Board—Novo Nordisk; Speakers Bureau—Novo Nordisk

Warren Joseph: Speakers Bureau—Paratek Pharma

Hadar Lev-Tov: AbbVie— Advisory Board; Consultant—Molnycke, NextScience, Pfizer, Inc.; Grant/Research Support—Essity, Molnycke, NextScience,  Vomaris Inc

Edward Loftus: Consultant – AbbVie, Alvotech, Amgen, Astellas, Avalo, Boehringer Ingelheim, Bristol-Myers Squibb, Celltrion Healthcare, Eli Lilly, Fresenius Kabi, Genentech, Gilead, GlaxoSmithKline, Gossamer Bio, Iota Biosciences, Iterative Health, Janssen, Morphic, Ono, Protagonist, Sun, Surrozen, Takeda, TR1X, UCB; research support – Janssen, Takeda, AbbVie, UCB, Genentech, Gilead, Celgene/Receptos, Bristol-Myers Squibb, Theravance, Gossamer Bio​

Millie Long: Consultant – AbbVie, Takeda, Janssen, Pfizer, Lilly, BMS, Prometheus, Target RWE, Intercept, Roivant; research support – Takeda, Pfizer, Lilly​

Brian Machler: Speaker's Bureau—Sanofi Regeneron

Paul Michael: Consultant — Philips, Abbott, Boston Scientific; Speakers' Bureau—Medtronic

Caterina Minniti: Advisory Board—Global Blood Therapeutics; Consultant—Agios, Bluebird Bio, Chiesi, CSL Behring, Forma Therapeutics, Global Blood Therapeutics, Novartis, Roche; Speakers Bureau— Novartis

Elliot Mostow: Other Financial or Material Support, Associate Editor, Dermatology Channel, Practiceupdate.com—Elsevier

Christine Murphy: Advisory Board—3M/KCI, URGO, Convatec; Consultant—3M/KCI, Convatec

Mary Anne Obst: Co-patent owner—Fistula Solution; Speakers Bureau—KCI

Alex Ortega: Advisory Board— Boehringer Ingelheim, Bristol-Meyers Squibb, Janssen Biotech; Consultant—Corvus Pharma,  Genetech, Guidepoint Global; Grant/Research Support—AbbVie Inc, Eli Lilly Pharmaceuticals, Janssen Biotech, Pfizer, Inc

George Pliagas: Consultant—CARDIOVASCULAR SYSTEMS INC.; Speakers Bureau—Asahi, CARDIOVASCULAR SYSTEMS INC., Medtronic, Philips; Stockholder—Penumbra

David Rubin: Consultant/Advisor– Abbvie, Altrubio, Aslan Pharmaceuticals, Athos Therapeutics, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Ltd., Bristol-Myers Squibb, Celgene, Chronicles, Syneos, ClostraBio, Connect BioPharma, Eco R1, Genentech/Roche, Gilead Sciences, Iterative Health, Image Analysis Group, Janssen Pharmaceuticals, Kaleido Biosciences, Lilly, Pfizer, Prometheus Biosciences, Reistone, Seres Therapeutics, Takeda, Target RWE, Trellus Health; Grant Support – Takeda, Helmsley Charitable Trust, GastroIntestinal Research Foundation; Board of Trustees – Crohn’s & Colitis Foundation, Cornerstones Health, Inc​

Bruce Sands: Consultant or received speaker’s fees from AbbVie, Abivax, Adiso Therapeutics, Alimentiv, Amgen, Arena Pharmaceuticals, Artizan Biosciences, Artugen Therapeutics, AstraZeneca, Bacainn Therapeutics, Biora Therapeutics, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol Myers Squibb, Calibr, Celltrion, ClostraBio, Connect Biopharm, Cytoki Pharma, Eli Lilly and Company, Enthera, Evommune, Ferring, Fresenius Kabi, Galapagos, Gilead Sciences, Genentech, Glaxo SmithKline, Gossamer Bio, HMP Acquisition, Imhotex, Immunic, InDex Pharmaceuticals, Innovation Pharmaceuticals, Inotrem, Ironwood Pharmaceuticals, Janssen, Johnson & Johnson, Kaleido, Kalyope, Merck, MiroBio, Morphic Therapeutic, MRM Health, OSE Immunotherapeutics, Pfizer, Progenity, Prometheus Biosciences, Prometheus Laboratories, Protagonist Therapeutics, Q32 Bio, RedHill Biopharma, Sun Pharma Global, Surrozen, Synlogic Operating Company, Takeda, Target RWE, Theravance Biopharma R&D, TLL Pharmaceutical, USWM Enterprises, Ventyx Biosciences, Viela Bio, and stock options from Ventyx Biosciences. ​

Heather Woolery-Lloyd: Grant/Research Support—Allergan, Galderma, Pfizer; Speakers Bureau—EPI Health, Ortho Dermatologics; Major Stockholder— Somabella Laboratories, LLC

PLANNING COMMITTEE

Susie Seaman, NP, MSN, CWCN, CWS (nurse planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California

Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).

HMP Education planners and staff include Kristin Ciszeski; Krystal Scharon; Samantha Joy; Randy Robbin; and Andrea Zimmerman, EdD.

No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).

ADA Statement

HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodation(s), please submit a request to contact the support team. 

Commercial Support

No commercial interest provided financial support for this continuing education activity. Please see agenda for individual session support.  

Contact Us

For immediate assistance, please explore our HMP Education Help Center or chat with our Virtual CE Assistant, which can answer most common questions related to claiming credits and the HMP Education website. If you have a question or grievance that cannot be answered by our Virtual CE assistant and Help Center, please submit a request to contact the support team. Our accreditation and compliance team will respond to your inquiry within one business day. 

Disclaimers

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own provider. 

The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering. 

Privacy Policy

HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.  

Copyright © 2025 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.